Larimar Therapeutics, Inc.

NASDAQ:LRMR

Biotechnology

Healthcare
$3.23 +0.99%

+$0.04 today

Market cap
$337.45M
Beta
0.82
P/E (TTM)
-1.8
EPS (TTM)
-$1.95
52W Low $2.22High $6.42

Volume 1.41M

Average 1.73M

LRMR Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How LRMR compares with its peers on the latest reported figures

LRMR Competitors Peer median
Gross Margin for LRMR and competitors
Company Period LTM level YoY 3-year change
ACIUAC Immune S.A.LTM Mar 2026100.0% +0.0 pp+0.0 pp
KRROKorro Bio, Inc.LTM Mar 202673.2% -26.8 pp—
AMRNAmarin Corporation plcLTM Mar 202652.5% +18.0 pp-9.1 pp
ALTAltimmune, Inc.LTM Mar 2026-41519.4% -41619.4 pp+0.0 pp
LRMRLarimar Therapeutics, Inc.FY2025— ——
ANROAlto Neuroscience, Inc.FY2025— ——
ANNXAnnexon, Inc.FY2025— ——
KYTXKyverna Therapeutics, Inc.FY2025— ——
DBVTDBV Technologies S.A.FY2025— ——
LXEOLexeo Therapeutics, Inc. Common StockFY2025— ——
ENGNenGene Holdings Inc.FY2025— ——
Peer median (excluding LRMR) 62.8%-13.4 pp+0.0 pp

Competitors are the stored peer set for LRMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development38.4M24.25M27.67M73.28M154.22M
Selling, General & Admin12.07M12.28M14.09M17.61M18.27M
Operating Expenses50.47M36.53M41.76M90.89M172.5M
Depreciation & Amortization326K318K311K318K350K
EBITDA(50.31M)(35.04M)(36.64M)(80.29M)(165.32M)
EBITDA Margin—————
Operating Income(50.47M)(36.53M)(41.76M)(90.89M)(172.5M)
Operating Margin—————
Interest Income00000
Interest Expense00000
Other Income / Expenses(171K)1.17M4.81M10.29M6.82M
Income Before Tax(50.64M)(35.36M)(36.95M)(80.6M)(165.67M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(50.64M)(35.36M)(36.95M)(80.6M)(165.67M)
Net Margin—————
EPS (Basic)(2.93)(1.33)(0.84)(1.32)(2.27)
EPS (Diluted)(2.93)(1.33)(0.84)(1.32)(2.27)
Weighted Avg Shares17.16M25.76M43.9M61.26M72.95M
Weighted Avg Shares (Diluted)17.16M25.76M43.9M61.26M72.95M

Larimar Therapeutics, Inc.

NASDAQ:LRMR

Intrinsic Alpha fair value

Locked

Current Price

$3.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.